Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Collagen proportionate area is an independent predictor of long-term outcome in patients with non-alcoholic fatty liver disease.

Buzzetti E, Hall A, Ekstedt M, Manuguerra R, Guerrero Misas M, Covelli C, Leandro G, Luong T, Kechagias S, Manesis EK, Pinzani M, Dhillon AP, Tsochatzis EA.

Aliment Pharmacol Ther. 2019 May;49(9):1214-1222. doi: 10.1111/apt.15219. Epub 2019 Mar 18.

PMID:
30882933
2.

Metastatic Signet-Ring Cell Carcinoma of the Skin.

Chrysanthos NV, Nezi V, Zafiropoulou R, Papatheodoridis G, Manesis E.

Am J Gastroenterol. 2018 Oct;113(10):1427. doi: 10.1038/s41395-018-0099-3. No abstract available.

PMID:
29891852
3.

Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis.

Herrmann E, de L├ędinghen V, Cassinotto C, Chu WC, Leung VY, Ferraioli G, Filice C, Castera L, Vilgrain V, Ronot M, Dumortier J, Guibal A, Pol S, Trebicka J, Jansen C, Strassburg C, Zheng R, Zheng J, Francque S, Vanwolleghem T, Vonghia L, Manesis EK, Zoumpoulis P, Sporea I, Thiele M, Krag A, Cohen-Bacrie C, Criton A, Gay J, Deffieux T, Friedrich-Rust M.

Hepatology. 2018 Jan;67(1):260-272. doi: 10.1002/hep.29179. Epub 2017 Nov 15. Review.

4.

Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study.

Kalafateli M, Zisimopoulos K, Vourli G, Rigamonti C, Goulis J, Manesis E, Manolakopoulos S, Tsochatzis E, Georgiou A, Diamantopoulou G, Thomopoulos K, Gogos C, Touloumi G, Akriviadis E, Lambropoulou-Karatza C, Triantos C.

Dig Dis Sci. 2017 May;62(5):1363-1372. doi: 10.1007/s10620-017-4504-3. Epub 2017 Mar 1.

PMID:
28251503
5.

Association of antiviral therapy with reduced disease progression in chronic Hepatitis B patients: Results from a nation-wide cohort study.

Vourli G, Papatheodoridis G, Raptopoulou M, Dalekos GN, Hounta A, Nikolopoulou G, Zouboulis-Vafeiadis I, Manesis E, Kitis G, Gogos C, Ketikoglou I, Hatzis G, Vasilialdis T, Karatapanis S, Mimidis K, Drakoulis C, Touloumi G, The Hepnet-Greece.

Hippokratia. 2016 Jul-Sep;20(3):214-221.

6.

Keratin 19 protein expression is an independent predictor of survival in human hepatocellular carcinoma.

Fatourou E, Koskinas J, Karandrea D, Palaiologou M, Syminelaki T, Karanikolas M, Felekouras E, Antoniou E, Manesis EK, Delladetsima J, Tiniakos D.

Eur J Gastroenterol Hepatol. 2015 Sep;27(9):1094-102. doi: 10.1097/MEG.0000000000000398.

PMID:
26011233
7.

Genotype 4 HCV infection is difficult to cure with pegylated interferon and ribavirin. Results from a Greek Nationwide Cohort Study.

Anagnostou O, Manolakopoulos S, Bakoyannis G, Papatheodoridis G, Zisouli A, Raptopoulou-Gigi M, Manesis E, Ketikoglou I, Dalekos G, Gogos C, Vassiliadis T, Tzourmakliotis D, Karatapanis S, Kanatakis S, Zoumpoulis -, Hounta A, Koutsounas S, Giannoulis G, Tassopoulos N, Touloumi G.

Hippokratia. 2014 Jan;18(1):57-64.

8.

Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort.

Papatheodoridis GV, Manolakopoulos S, Touloumi G, Nikolopoulou G, Raptopoulou-Gigi M, Gogos C, Vafiadis-Zouboulis I, Karamanolis D, Chouta A, Ilias A, Drakoulis C, Mimidis K, Ketikoglou I, Manesis E, Mela M, Hatzis G, Dalekos GN; HepNet.Greece Study Group.

J Viral Hepat. 2015 Feb;22(2):120-7. doi: 10.1111/jvh.12283. Epub 2014 Jul 15.

PMID:
25040685
9.

Immigration, European union and health issues: a commentary.

Manesis EK.

Dig Liver Dis. 2014 Jan;46(1):25-6. doi: 10.1016/j.dld.2013.10.004. Epub 2013 Nov 26. No abstract available.

PMID:
24290870
10.

Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapy.

Papatheodoridis G, Goulis J, Manolakopoulos S, Margariti A, Exarchos X, Kokkonis G, Hadziyiannis E, Papaioannou C, Manesis E, Pectasides D, Akriviadis E.

J Hepatol. 2014 Jan;60(1):62-8. doi: 10.1016/j.jhep.2013.08.023. Epub 2013 Sep 6.

PMID:
24012614
11.

Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.

Manesis EK, Vourli G, Dalekos G, Vasiliadis T, Manolaki N, Hounta A, Koutsounas S, Vafiadis I, Nikolopoulou G, Giannoulis G, Germanidis G, Papatheodoridis G, Touloumi G.

J Hepatol. 2013 Nov;59(5):949-56. doi: 10.1016/j.jhep.2013.07.005. Epub 2013 Jul 10.

PMID:
23850875
12.

Ultrasensitive amplification refractory mutation system real-time PCR (ARMS RT-PCR) assay for detection of minority hepatitis B virus-resistant strains in the era of personalized medicine.

Ntziora F, Paraskevis D, Haida C, Manesis E, Papatheodoridis G, Manolakopoulos S, Elefsiniotis I, Karamitros T, Vassilakis A, Hatzakis A.

J Clin Microbiol. 2013 Sep;51(9):2893-900. doi: 10.1128/JCM.00936-13. Epub 2013 Jun 26.

13.

Development and assessment of a novel real-time PCR assay for quantitation of hepatitis D virus RNA to study viral kinetics in chronic hepatitis D.

Katsoulidou A, Manesis E, Rokka C, Issaris C, Pagoni A, Sypsa V, Hatzakis A.

J Viral Hepat. 2013 Apr;20(4):256-62. doi: 10.1111/jvh.12000. Epub 2012 Sep 13.

PMID:
23490370
14.

Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients.

Manolakopoulos S, Striki A, Deutsch M, Mela M, Ketikoglou I, Tzourmakliotis D, Manesis EK, Papatheodoridis GV.

Liver Int. 2011 Nov;31(10):1525-32. doi: 10.1111/j.1478-3231.2011.02616.x. Epub 2011 Aug 11.

PMID:
22093327
15.

Effect of antiviral therapy on the immunohistochemical expression of bcl-xL and bax protein in patients with HBeAg-negative chronic hepatitis B.

Cholongitas E, Papatheodoridis GV, Manesis EK, Petraki K, Tiniakos D, Hadziyannis SJ.

J Med Virol. 2011 Jul;83(7):1165-71. doi: 10.1002/jmv.21780.

PMID:
21567420
16.

Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.

Papatheodoridis GV, Manolakopoulos S, Touloumi G, Vourli G, Raptopoulou-Gigi M, Vafiadis-Zoumbouli I, Vasiliadis T, Mimidis K, Gogos C, Ketikoglou I, Manesis EK; HEPNET. Greece Cohort Study Group.

Gut. 2011 Aug;60(8):1109-16. doi: 10.1136/gut.2010.221846. Epub 2011 Jan 26.

PMID:
21270118
17.

Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.

Manesis EK, Papatheodoridis GV, Tiniakos DG, Hadziyannis ES, Agelopoulou OP, Syminelaki T, Papaioannou C, Nastos T, Karayiannis P.

J Hepatol. 2011 Jul;55(1):61-8. doi: 10.1016/j.jhep.2010.10.027. Epub 2010 Dec 5.

PMID:
21145875
18.

Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C.

Manolakopoulos S, Deutsch MJ, Anagnostou O, Karatapanis S, Tiniakou E, Papatheodoridis GV, Georgiou E, Manesis E, Tzourmakliotis D, Archimandritis AJ.

Liver Int. 2010 Nov;30(10):1454-60. doi: 10.1111/j.1478-3231.2010.02341.x. Epub 2010 Sep 16.

PMID:
20846344
19.

Increased arterial stiffness and impaired endothelial function in nonalcoholic Fatty liver disease: a pilot study.

Vlachopoulos C, Manesis E, Baou K, Papatheodoridis G, Koskinas J, Tiniakos D, Aznaouridis K, Archimandritis A, Stefanadis C.

Am J Hypertens. 2010 Nov;23(11):1183-9. doi: 10.1038/ajh.2010.144. Epub 2010 Jul 15.

PMID:
20634799
20.

Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection.

Vassilopoulos D, Apostolopoulou A, Hadziyannis E, Papatheodoridis GV, Manolakopoulos S, Koskinas J, Manesis EK, Archimandritis AI.

Ann Rheum Dis. 2010 Jul;69(7):1352-5. doi: 10.1136/ard.2009.127233. Epub 2010 May 14.

PMID:
20472596
21.

Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C.

Tsochatzis E, Papatheodoridis GV, Koliaraki V, Hadziyannis E, Kafiri G, Manesis EK, Mamalaki A, Archimandritis AJ.

J Viral Hepat. 2010 Nov;17(11):800-6. doi: 10.1111/j.1365-2893.2009.01244.x.

PMID:
20002304
22.

Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease.

Papatheodoridis GV, Hadziyannis E, Tsochatzis E, Georgiou A, Kafiri G, Tiniakos DG, Margariti K, Manolakopoulos S, Manesis EK, Archimandritis AJ.

J Clin Gastroenterol. 2010 Apr;44(4):e87-95. doi: 10.1097/MCG.0b013e3181c0945a.

PMID:
19881359
23.

The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre.

Giannousis IP, Papatheodoridis GV, Deutsch MJ, Manolakopoulos SG, Manesis EK, Koskinas JS, Archimandritis AJ.

Eur J Gastroenterol Hepatol. 2010 Feb;22(2):172-9. doi: 10.1097/MEG.0b013e328331115b.

PMID:
19738477
24.

Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease.

Schina M, Koskinas J, Tiniakos D, Hadziyannis E, Savvas S, Karamanos B, Manesis E, Archimandritis A.

Hepatol Res. 2009 Oct;39(10):972-8. doi: 10.1111/j.1872-034X.2009.00534.x. Epub 2009 Jul 13.

PMID:
19624771
25.

Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre study.

Tsochatzis E, Manolakopoulos S, Papatheodoridis GV, Hadziyannis E, Triantos C, Zisimopoulos K, Goulis I, Tzourmakliotis D, Akriviadis E, Manesis EK, Archimandritis AJ.

Aliment Pharmacol Ther. 2009 Nov 1;30(9):947-54. doi: 10.1111/j.1365-2036.2009.04094.x. Epub 2009 Jul 9.

26.

Hepatic parenchyma resection using stapling devices: peri-operative and long-term outcome.

Delis SG, Bakoyiannis A, Karakaxas D, Athanassiou K, Tassopoulos N, Manesis E, Ketikoglou I, Papakostas P, Dervenis C.

HPB (Oxford). 2009 Feb;11(1):38-44. doi: 10.1111/j.1477-2574.2008.00003.x.

27.

Quantitative detection of the M204V hepatitis B virus minor variants by amplification refractory mutation system real-time PCR combined with molecular beacon technology.

Ntziora F, Paraskevis D, Haida C, Magiorkinis E, Manesis E, Papatheodoridis G, Manolakopoulos S, Beloukas A, Chryssoy S, Magiorkinis G, Sypsa V, Hatzakis A.

J Clin Microbiol. 2009 Aug;47(8):2544-50. doi: 10.1128/JCM.00045-09. Epub 2009 Jun 24.

28.

Values for upper limit of normal should be given for liver enzymes.

Manesis EK.

Hepatology. 2009 May;49(5):1783-4; author reply 1784. doi: 10.1002/hep.22788. No abstract available.

PMID:
19402113
29.

Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B.

Tsochatzis E, Papatheodoridis GV, Manolakopoulos S, Tiniakos DG, Manesis EK, Archimandritis AJ.

Scand J Gastroenterol. 2009;44(6):752-9. doi: 10.1080/00365520902803515.

PMID:
19296398
30.

Natural course of treated and untreated chronic HCV infection: results of the nationwide Hepnet.Greece cohort study.

Manesis EK, Papatheodoridis GV, Touloumi G, Karafoulidou A, Ketikoglou J, Kitis GE, Antoniou A, Kanatakis S, Koutsounas SJ, Vafiadis I; HEPNET.Greece Cohort Study.

Aliment Pharmacol Ther. 2009 May 15;29(10):1121-30. doi: 10.1111/j.1365-2036.2009.03974.x. Epub 2009 Feb 15.

31.

Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-control study.

Mavrogiannaki A, Karamanos B, Manesis EK, Papatheodoridis GV, Koskinas J, Archimandritis AJ.

J Viral Hepat. 2009 Jun;16(6):430-6. doi: 10.1111/j.1365-2893.2009.01077.x. Epub 2009 Feb 6.

PMID:
19200136
32.

Epidemiology, course and disease burden of chronic hepatitis B virus infection. HEPNET study for chronic hepatitis B: a multicentre Greek study.

Raptopoulou M, Papatheodoridis G, Antoniou A, Ketikoglou J, Tzourmakliotis D, Vasiliadis T, Manolaki N, Nikolopoulou G, Manesis E, Pierroutsakos I.

J Viral Hepat. 2009 Mar;16(3):195-202. doi: 10.1111/j.1365-2893.2008.01057.x. Epub 2008 Sep 26.

PMID:
19175881
33.

Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?

Papatheodoridis GV, Manesis EK, Manolakopoulos S, Elefsiniotis IS, Goulis J, Giannousis J, Bilalis A, Kafiri G, Tzourmakliotis D, Archimandritis AJ.

Hepatology. 2008 Nov;48(5):1451-9. doi: 10.1002/hep.22518.

PMID:
18924246
34.

Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.

Tsochatzis E, Papatheodoridis GV, Hadziyannis E, Georgiou A, Kafiri G, Tiniakos DG, Manesis EK, Archimandritis AJ.

Scand J Gastroenterol. 2008;43(9):1128-36. doi: 10.1080/00365520802085387.

PMID:
18609175
35.

Aetiology and outcome of acute hepatic failure in Greece: experience of two academic hospital centres.

Koskinas J, Deutsch M, Kountouras D, Kostopanagiotou G, Arkadopoulos N, Smyrniotis V, Rapti I, Manesis E, Archimandritis A.

Liver Int. 2008 Jul;28(6):821-827. Epub 2008 May 19.

PMID:
18492016
36.

Changes of liver and muscle enzymes activity in patients with rigor.

Sevastos N, Manesis EK, Savvas SP, Galiatsatos N, Papatheodoridis GV, Archimandritis AJ.

Eur J Intern Med. 2008 Mar;19(2):109-14. doi: 10.1016/j.ejim.2007.05.013. Epub 2008 Jan 10.

PMID:
18249306
37.

Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.

Papatheodoridis GV, Chrysanthos N, Hadziyannis E, Cholongitas E, Manesis EK.

J Viral Hepat. 2008 Jun;15(6):434-41. doi: 10.1111/j.1365-2893.2007.00957.x. Epub 2008 Jan 9.

PMID:
18194171
38.
39.

Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.

Papatheodoridis GV, Hadziyannis E, Tsochatzis E, Chrysanthos N, Georgiou A, Kafiri G, Manolakopoulos S, Tiniakos DG, Giannousis I, Manesis EK, Archimandritis AJ.

Gut. 2008 Apr;57(4):500-6. Epub 2007 Nov 19.

PMID:
18025069
40.

Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.

Tsochatzis E, Papatheodoridis GV, Manesis EK, Kafiri G, Tiniakos DG, Archimandritis AJ.

Aliment Pharmacol Ther. 2008 Jan 1;27(1):80-9. Epub 2007 Oct 5.

41.

Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C.

Tsochatzis E, Papatheodoridis GV, Manesis EK, Chrysanthos N, Kafiri G, Archimandritis AJ.

Dig Liver Dis. 2007 Oct;39(10):936-42. Epub 2007 Aug 27.

PMID:
17720637
42.

Serum hepatitis B virus-DNA cutoff levels in hepatitis B e antigen-negative chronic hepatitis B virus infection.

Papatheodoridis GV, Manesis EK, Manolakopoulos S, Archimandritis AJ.

Hepatology. 2007 Aug;46(2):606-7; author reply 607. No abstract available.

PMID:
17661409
43.

Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring.

Manesis EK, Schina M, Le Gal F, Agelopoulou O, Papaioannou C, Kalligeros C, Arseniou V, Manolakopoulos S, Hadziyannis ES, Gault E, Koskinas J, Papatheodoridis G, Archimandritis AJ.

Antivir Ther. 2007;12(3):381-8.

PMID:
17591028
44.
45.

Acute ischemic injury due to a giant intrahepatic hematoma: A complication of percutaneous liver biopsy.

Tsochatzis E, Deutsch M, Zaphyropoulou R, Koskinas J, Manesis E.

Eur J Intern Med. 2007 Jul;18(4):339-41. Epub 2007 May 24.

PMID:
17574114
46.

First appearance of Crohn's disease following infliximab treatment for spondylarthropathy.

Tsochatzis E, Vassilopoulos D, Manesis EK, Papatheodoridis G, Bousiotou A, Hadziyannis E, Archimandritis AJ.

Scand J Gastroenterol. 2007 Jun;42(6):784-5. No abstract available.

PMID:
17506005
47.

Prediction of treatment-related HBsAg loss in HBeAG-negative chronic hepatitis B: a clue from serum HBsAg levels.

Manesis EK, Hadziyannis ES, Angelopoulou OP, Hadziyannis SJ.

Antivir Ther. 2007;12(1):73-82.

PMID:
17503750
48.

Liver involvement in acute vaso-occlusive crisis of sickle cell disease: prevalence and predisposing factors.

Koskinas J, Manesis EK, Zacharakis GH, Galiatsatos N, Sevastos N, Archimandritis AJ.

Scand J Gastroenterol. 2007 Apr;42(4):499-507.

PMID:
17454861
49.

Non-alcoholic fatty liver and cardiovascular disease: an emerging relationship.

Baou K, Vlachopoulos C, Manesis E, Archimandritis A, Stefanadis C.

Hellenic J Cardiol. 2007 Jan-Feb;48(1):37-41. Review. No abstract available.

50.

Thrombotic thrombocytopenic purpura with fatal outcome in a patient with chronic hepatitis C treated with pegylated interferon-a/2b.

Deutsch M, Manesis EK, Hadziyannis E, Vassilopoulos D, Archimandritis AJ.

Scand J Gastroenterol. 2007 Mar;42(3):408-9. No abstract available.

PMID:
17354123

Supplemental Content

Loading ...
Support Center